|
1
|
Schneider N and Yvon C: A review of
multidomain interventions to support healthy cognitive ageing. J
Nutr Health Aging. 17:252–257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De-Paula VJ, Radanovic M, Diniz BS and
Forlenza OV: Alzheimer’s disease. Subcell Biochem. 65:329–352.
2012. View Article : Google Scholar
|
|
3
|
Grundman M, Petersen RC, Ferris SH, et al;
Alzheimer’s Disease Cooperative Study. Mild cognitive impairment
can be distinguished from Alzheimer disease and normal aging for
clinical trials. Arch Neurol. 61:59–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chico L, Simoncini C, Lo Gerfo A, et al:
Oxidative stress and APO E polymorphisms in Alzheimer’s disease and
in mild cognitive impairment. Free Radic Res. 47:569–576. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Izco M, Martínez P, Corrales A, et al:
Changes in the brain and plasma Aβ peptide levels with age and its
relationship with cognitive impairment in the APPswe/PS1dE9 mouse
model of Alzheimer’s disease. Neuroscience. 263:269–279. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kosenko EA, Solomadin IN, Tikhonova LA,
Reddy VP, Aliev G and Kaminsky YG: Pathogenesis of Alzheimer
disease: role of oxidative stress, amyloid-β peptides, systemic
ammonia and erythrocyte energy metabolism. CNS Neurol Disord Drug
Targets. 13:112–119. 2014. View Article : Google Scholar
|
|
7
|
Peacock JM, Folsom AR, Knopman DS, Mosley
TH, Goff DC Jr and Szklo M: Dietary antioxidant intake and
cognitive performance in middle-aged adults. The Atherosclerosis
Risk in Communities (ARIC) Study investigators. Public Health Nutr.
3:337–343. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harrison FE: A critical review of vitamin
C for the prevention of age-related cognitive decline and
Alzheimer’s disease. J Alzheimers Dis. 29:711–726. 2012.
|
|
9
|
Grodstein F, O’Brien J, Kang JH, Dushkes
R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M
and Sesso HD: Long-term multivitamin supplementation and cognitive
function in men: a randomized trial. Ann Intern Med. 159:806–814.
2013. View Article : Google Scholar :
|
|
10
|
Ristow M: Unraveling the truth about
antioxidants: mitohormesis explains ROS-induced health benefits.
Nat Med. 20:709–711. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yakushiji Y, Horikawa E, Eriguchi M, Nanri
Y, Nishihara M, Hirotsu T and Hara H: Norms of the Mini-Mental
state Examination for Japanese subjects that underwent
comprehensive brian examinations: the Kashima Scan Study. Intern
Med. 53:2447–2453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeong JW, Kim KW, Lee DY, Lee SB, Park JH,
Choi EA, Choe JY, Do YJ, Ryang JS, Roh HA, Park YS, Choi Y and Woo
JI: A normative study of the Revised Hasegawa Dementia Scale:
comparison of demographic influences between the Revised Hasegawa
Dementia Scale and the Mini-Mental Status Examination. Dement
Geriatr Cogn Disord. 24:288–293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krishnan S and Rani P: Evaluation of
selenium, redox status and their association with plasma
amyloid/tau in Alzheimer’s disease. Biol Trace Elem Res.
158:158–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hruska Z and Dohanich GP: The effects of
chronic estradiol treatment on working memory deficits induced by
combined infusion of beta-amyloid (1–42) and ibotenic acid. Horm
Behav. 52:297–306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kolosova NG, Shcheglova TV, Sergeeva SV
and Loskutova LV: Long-term antioxidant supplementation attenuates
oxidative stress markers and cognitive deficits in
senescent-accelerated OXYS rats. Neurobiol Aging. 27:1289–1297.
2006. View Article : Google Scholar
|
|
16
|
Karpińska A and Gromadzka G: Oxidative
stress and natural antioxidant mechanisms: the role in
neurodegeneration. From molecular mechanisms to therapeutic
strategies. Postepy Hig Med Dosw (Online). 67:43–53. 2013.(In
Polish). View Article : Google Scholar
|
|
17
|
Jomova K, Vondrakova D, Lawson M and Valko
M: Metals, oxidative stress and neurodegenerative disorders. Mol
Cell Biochem. 345:91–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joshi YB and Praticò D: Vitamin E in
aging, dementia and Alzheimer’s disease. Biofactors. 38:90–97.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boyd-Kimball D, Sultana R, Mohmmad-Abdul H
and Butterfield DA: Rodent Abeta(1–42) exhibits oxidative stress
properties similar to those of human Abeta(1–42): Implications for
proposed mechanisms of toxicity. J Alzheimers Dis. 6:515–525.
2004.PubMed/NCBI
|
|
20
|
Sen Gupta R, Sen Gupta E, Dhakal BK,
Thakur AR and Ahnn J: Vitamin C and vitamin E protect the rat
testes from cadmium-induced reactive oxygen species. Mol Cells.
17:132–139. 2004.PubMed/NCBI
|
|
21
|
Zhang Y, Li Q, Liu X, Zhu H, Song A and
Jiao J: Antioxidant and micronutrient-rich milk formula reduces
lead poisoning and related oxidative damage in lead-exposed mice.
Food Chem Toxicol. 57:201–208. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karajibani M, Hashemi M, Montazerifar F
and Dikshit M: Effect of vitamin E and C supplements on antioxidant
defense system in cardiovascular disease patients in Zahedan,
southeast Iran. J Nutr Sci Vitaminol (Tokyo). 56:436–440. 2010.
View Article : Google Scholar
|
|
23
|
Martin A: Antioxidant vitamins E and C and
risk of Alzheimer’s disease. Nutr Rev. 61:69–73. 2013.
|
|
24
|
Grodstein F, Chen J and Willett WC:
High-dose antioxidant supplements and cognitive function in
community-dwelling elderly women. Am J Clin Nutr. 77:975–984.
2003.PubMed/NCBI
|
|
25
|
Ogunniyi A, Baiyewu O, Gureje O, et al:
Epidemiology of dementia in Nigeria: results from the
Indianapolis-Ibadan study. Eur J Neurol. 7:485–490. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martin A, Youdim K, Szprengiel A,
Shukitt-Hale B and Joseph J: Roles of vitamins E and C on
neurodegenerative diseases and cognitive performance. Nutr Rev.
60:308–326. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Trushina E and Mielke MM: Recent advances
in the application of metabolomics to Alzheimer’s Disease. Biochim
Biophys Acta. 1842:1232–1239. 2014. View Article : Google Scholar
|
|
28
|
Swomley AM, Förster S, Keeney JT, Triplett
J, Zhang Z, Sultana R and Butterfield DA: Abeta, oxidative stress
in Alzheimer disease: Evidence based on proteomics studies. Biochim
Biophys Acta. 1842:1248–1257. 2014. View Article : Google Scholar
|
|
29
|
Zhao Y and Zhao B: Oxidative stress and
the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev.
2013:3165232013. View Article : Google Scholar
|
|
30
|
Kocoska-Maras L, Rådestad AF, Carlström K,
Bäckström T, von Schoultz B and Hirschberg AL: Cognitive function
in association with sex hormones in postmenopausal women. Gynecol
Endocrinol. 29:59–62. 2013. View Article : Google Scholar
|
|
31
|
Rodgers SP, Bohacek J and Daniel JM:
Transient estradiol exposure during middle age in ovariectomized
rats exerts lasting effects on cognitive function and the
hippocampus. Endocrinology. 151:1194–1203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Glinskii OV, Huxley VH, Glinskii VV, Rubin
LJ and Glinsky VV: Pulsed estrogen therapy prevents post-OVX
porcine dura mater microvascular network weakening via a
PDGF-BB-dependent mechanism. PLoS One. 8:e829002013. View Article : Google Scholar : PubMed/NCBI
|
